Literature DB >> 30903415

Clinical, laboratory features, and prognostic factors in adult acute transverse myelitis: an Italian multicenter study.

Pasquale Annunziata1,2, Gianni Masi3, Chiara Cioni3, Matteo Gastaldi4, Enrico Marchioni5, Emanuele D'amico6, Francesco Patti6, Alice Laroni7,8, Gianluigi Mancardi7,8, Francesca Vitetta9, Patrizia Sola9.   

Abstract

OBJECTIVES: We compared the clinical, laboratory, and radiological features of different subgroups of acute transverse myelitis (ATM) diagnosed according to the criteria established by the Transverse Myelitis Consortium Working Group (TMCWG) as well as of non-inflammatory acute transverse myelopathies (NIATM) to identify possible short- and long-term prognostic factors.
METHODS: A multicenter and retrospective study comprising 110 patients with ATM and 15 NIATM admitted to five Italian neurological units between January 2010 and December 2014 was carried out.
RESULTS: A significantly higher frequency of isolated sensory disturbances at onset in ATM than in NIATM patients (chi-square = 14. 7; P = 0.005) and a significantly higher frequency of motor symptoms in NIATM than ATM (chi-square = 12.4; P = 0.014) was found. ATM patients with high disability at discharge had more motor-sensory symptoms without (OR = 3.87; P = 0.04) and with sphincter dysfunction at onset (OR = 7.4; P = 0.0009) compared to those with low disability. Higher age (OR = 1.08; P = 0.001) and motor-sensory-sphincter involvement at onset (OR = 9.52; P = 0.002) were significantly associated with a high disability score at discharge and after a median 1-year follow-up.
CONCLUSIONS: The diagnosis of ATM may prevail respect to that of NIATM when a sensory symptomatology at onset occurs. In ATM, patients older and with motor-sensory involvement with or without sphincter impairment at admission could experience a major risk of poor prognosis both at discharge and at longer time requiring a timely and more appropriate treatment.

Entities:  

Keywords:  Connective autoimmune disorders; Disability; Multiple sclerosis; Neuromyelitis optica spectrum disorders; Prognosis; Transverse myelitis

Mesh:

Substances:

Year:  2019        PMID: 30903415     DOI: 10.1007/s10072-019-03830-6

Source DB:  PubMed          Journal:  Neurol Sci        ISSN: 1590-1874            Impact factor:   3.307


  4 in total

Review 1.  Clinical characteristics, radiological features and prognostic factors of transverse myelitis following COVID-19 vaccination: A systematic review.

Authors:  Vahid Reza Ostovan; Mohammad Ali Sahraian; Neda Karazhian; Mahtab Rostamihosseinkhani; Marzieh Salimi; Hoda Marbooti
Journal:  Mult Scler Relat Disord       Date:  2022-07-06       Impact factor: 4.808

2.  Delayed diagnosis of myelitis in a patient with Vogt-Koyanagi-Harada disease: a case report.

Authors:  Dongwoo Yu; Tae Uk Kim; Min Cheol Chang
Journal:  J Int Med Res       Date:  2021-03       Impact factor: 1.671

3.  Transverse myelitis after SARS-CoV-2 infection: Report of two cases with COVID-19.

Authors:  Soroor Advani; Seyyed Mohammad-Mahdi Hosseini; Alireza Zali; Davood Ommi; Alireza Fatemi; Reza Jalili Khoshnoud; Farzad Ashrafi
Journal:  Clin Case Rep       Date:  2021-12-18

4.  Clinical characteristics and outcome of neurosarcoidosis-associated myelitis: A retrospective cohort study and review of the literature.

Authors:  Jessica Y C Nolte; Leroy Ten Dam; Diederik van de Beek; Matthijs C Brouwer
Journal:  Eur J Neurol       Date:  2022-03-03       Impact factor: 6.288

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.